News Medical on MSN
Whole-genome Sequencing May Optimize PARP Inhibitor Use
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback